[1] YAN Q，WU Y P.Culture clinical pharmacist and develop clinical pharmacy[J] .J China Pharm(中国药房)，2000，11(3)：107-108. [2] HAMMOND R W，SCHWARTZ A H，CAMPBELL M J，et al.Collaborative drug therapy Management by Pharmacists– 2003[J] .Pharmacotherapy,2003，23(9)： 1210-1225. [3] YE D Y，WANG J X，CHEN W B，et al. 20 years veview and expectation of Chinese clinical pharmacist[J] .Chin J Clin Pharm(中国临床药学杂志)，2001，10（1）：64-66. [4] American society of hospital pharmacises. ASHP stament on principles for including medications and pharmaceutical care in health care systems[J] . Am J Hosp Pharm，1993，50：756-757. [5] MANASSE H R JR. Medication use in an imperfect world，I： drug misadventuring as an issue of public policy[J] .Am J Hosp Pharm，1989，46：1093-1097. [6] ERNST F R，GRIZZLE A J. Drug-related morbidity and mortality： updating the cost-of-illness model[J] .J Am Pharm Assoc，2001，41：192-199. [7] KOHN L T，CORRIGAN J M，DONALDSON M S，et al. Institute of Medicine Report： To Err is Human： Building a Safer Health System[M] . Washington，DC： National Academy Press，1999. [8] ISETTS B J，BROWN L M，SCHONDELMEYER S W，et al.Quality assessment of a collaborative approach for decreasing drug-related morbidity and achieving therapeutic goals[J] .Arch Intern Med，2003，163(15)：1813-1820. [9] Agency for Healthcare Research and Quality. Patient safety task force fact sheet，[EB/OL] April 2001. Available from http：//www.ahrq.gov/qual/taskforce/psfactst.htm. Accessed June 25，2004. [10] KOHN L T，CORRIGAN J M，DONALDSON M S，et al. To Err is Human：Building a Safer Health System[M] . Washington，DC： National Academy Press，1999.